Will Targeted Therapies Shape the Future of Polymyalgia Rheumatica Treatment?
Crossref DOI link: https://doi.org/10.1007/s40674-025-00238-6
Published Online: 2025-11-14
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Leuret-Valles, Pablo
Carvajal Alegria, Guillermo
Text and Data Mining valid from 2025-11-14
Version of Record valid from 2025-11-14
Article History
Received: 17 June 2025
Accepted: 8 September 2025
First Online: 14 November 2025
Declarations
:
: GCA declares honoraria from Abbvie, BMS, Chugai, Eli Lilly, Novartis.